Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 356.7K | 224.9K | −131.8K (−36.9%) |
| Value | $306.1K | $87.5K | −$218.6K (−71.4%) |
New holders (3)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 94,916 | $36.9K | 0.00% |
| Two Sigma Securities, LLC | 22,189 | $8.63K | 0.00% |
| Barclays PLC | 3 | $1 | 0.00% |
Sold out (1)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| UBS Group AG | 32,787 | $28.2K |